The global blood culture test market size was estimated to be US$ 4.21 billion in 2021 and is expected to grow at a CAGR of 9.3% between 2023 to 2032.
Early identification of blood infections is essential to prevent further complications that are caused by pathogens. As the majority of blood infections are caused by bacterial infection their detection is necessary for disease prognosis. When the body's immune system reacts to an infection by damaging its tissues, blood infections can be potentially fatal. According to data from 2019, 6 million people die every year as a result of bloodstream illnesses, which affect 30 million individuals.
To identify the sort of infection, present in the bloodstream, doctors perform blood culture testing. As a result of its ability to combat a variety of germs, broad-spectrum intravenous antibiotics are now available for doctors to recommend to their patients. Because blood infections pose a serious health risk, doctors utilize automated blood culture testing to obtain reliable findings quickly. These elements are further anticipated to accelerate the blood culture test market growth.
Factors enabling growth of Blood Culture Tests:
Changing lifestyles and increasing pollution are key factors contributing to an increase in bacterial infections. The growing number of government initiatives in different countries to support early diagnosis has resulted in the rising adoption of blood culture tests to prevent future complications. For example, The Centers for Disease Control and Prevention launched the Get Ahead of Sepsis campaign as an educational initiative to protect Americans from sepsis.
The initiative focuses on early medical recognition and treatment of sepsis, as well as preventing infections that lead to sepsis condition. In addition, blood culture tests also assist doctors in detecting infections promptly, otherwise, infections in the blood can be fatal and lead to organ failure and even death. Furthermore, growing awareness of healthcare among the population has also led to the adoption of complete body tests, which is expected to drive revenue growth of the market over the forecast period.
Some of the secondary factors driving the growth of blood culture tests include the rising demand for early diagnosis of blood infections to prevent serious problems, an increase in hospitals, diagnostic facilities, and research labs, as well as increased usage of cutting-edge technology.
Several factors are causing the blood culture testing market to advance, including the rising incidence of bloodstream disorders, rising demand for quick diagnostic procedures, an increasing proportion of sepsis cases, high cost of disease management, growing elderly population, and prevalence of infectious diseases. The market for blood culture testing will also have more lucrative and alluring opportunities as a result of the rising approval rate of novel products, including tools and materials for Bloodstream Infection (BSI) diagnosis.
Additionally, during the forecast period, demand for automated blood culture methods will surpass that for manual methods and exhibit rapid growth rates. Currently, high-income nations are the primary regions where manual processes are being replaced by automated ones. The desire for automated procedures has increased due to technological advancements, which have improved the accuracy and efficiency of blood culture tests. These automated processes also give clinicians thorough test findings, improving the effectiveness of diagnosis and treatment delivery. Thus, the advancement in automated blood culture test equipment and the rising standard of living will help the market progression.
Biggest growth contributors:
Blood culture testing has increased as a result of an expansion in hospitals, diagnostic facilities, and research labs with cutting-edge equipment. Testing for blood infections in the body using blood cultures is essential. Blood culture tests are therefore advised by doctors to provide efficient care and medication. However, the tests call for lab facilities as well as different tools, mediums, and cultures. As a result, new and modern devices at hospitals, laboratories, and diagnostic facilities are recommended for blood culture tests. Such increase in usage is projected to increase as a result of these factors, which will support the Global Blood Culture Test market growth throughout the forecast period.
As per various statistics, the majority of blood culture tests are conducted in hospital laboratories. Each year, the higher prevalence of blood diseases and certain other chronic disorders is increasing the testing requirement of clinicians working in these hospitals. Having their laboratories allows these hospitals to perform these blood cultures more effectively and at any time of day. The growth of the medical sector and subsequent development of better test methods and equipment will induce a positive impact on the global blood culture testing market in the coming years.
Factors hampering the growth of Blood Culture Test:
It is anticipated that culture-based technology will lose market share to emerging, more sophisticated diagnostic methods like PCR and PNA-FiSH. These new and time-effective modern methods encourage greater accuracy in blood culture test results. These new methods may have a negative impact on the expansion and development of the blood culture test market in near future.
The blood culture testing process requires the collection and culturing of blood samples with extreme care and in a sterile environment. Furthermore, the staff involved in peripheral blood collection and culture needs to be trained properly. All these processes involve the employment of highly skilled employees, better infrastructure, and automated technology to increase the possibility of identifying germs. Shortage of skilled staff and the high cost of culture equipment may cause significant impediments for new and existing laboratories to expand their operations. Such issues are anticipated to hamper the market growth of blood culture tests during the forecast period.
Regional growth forecast:
The blood culture test market is dominated by the North American region. The largest concentration of laboratories and places where blood culture testing is used is in this area. Some of the biggest investors in the health care and medical sector include nations like the USA. The vast availability of blood culture testing for a variety of objectives to significant medical research and development initiatives are primary reasons for the dominance of the USA in this sector. This region is also the most significant hub for healthcare businesses which is expected to sustain the growth of the blood culture test market in the coming years.
For several emerging businesses, the Asia Pacific area is one of the most attractive destinations to expand in today's world. Since this region contains some of the most densely populated nations that are particularly susceptible to widespread blood-borne illnesses and infections. A rising number of laboratories have gained the potential to conduct commercial blood culture testing in this region due to this increased demand. Many nations in this region are also being encouraged by rising technical breakthroughs to adopt more sophisticated diagnostic techniques for performing blood cultures.
Key players and their strategies:
Many pharmaceutical and diagnostic companies are motivated to increase R&D in blood culture testings as a result of the yearly rise in sepsis and other BSI cases across the world. To establish operations and attract more funding and investments, many global enterprises working in the blood culture and diagnostics industries are focusing on APAC nations.
These are some of the most prominent players in the global blood culture testing market; Axiom Laboratories, Anaerobe Systems, Inc., Bulldog Bio, Inc., bioMérieux SA, BINDER GmbH, Bruker Corporation, Biobase Biotech Co., Ltd., Carl Zeiss AG, Danaher Corporation, Dickinson and Company, Luminex Corporation, Meditech Technologies India Private Limited, Nikon Corporation, IRIDICA, Becton, Thermo Fisher Scientific, Inc., Roche Diagnostics, T2 Biosystems, Inc., OpGen, Inc., Schenker Biological Technology Co., Ltd., and HiMedia Laboratories Pvt. Ltd.
By Method Type
The requirement for early detection of blood-borne pathogens to prevent serious complications, the expansion of health care and diagnostic facilities, as well as an increase in the adoption of cutting-edge equipment, are all factors that are fuelling the growth of the global blood culture tests market.
We have segmented the report for global blood culture tests market by geography by North America, Europe, Asia Pacific, South America, and MEA regions along with detailed breakdown.
The global blood culture tests market is estimated to exhibit a CAGR of 9.3% between 2023 to 2032.
The blood culture test market size was estimated to be US$ 4.21 billion in 2021.
The blood culture test market is dominated by the North American region. The largest concentration of laboratories and places where blood culture testing is used is in this area. Some of the biggest investors in the health care and medical sector include nations like the USA.
Axiom Laboratories, Anaerobe Systems, Inc., Bulldog Bio, Inc., bioMérieux SA, BINDER GmbH, Bruker Corporation, Biobase Biotech Co., Ltd., Carl Zeiss AG, Danaher Corporation, Dickinson and Company, Luminex Corporation, Meditech Technologies India Private Limited, Nikon Corporation, IRIDICA, Becton, Thermo Fisher Scientific, Inc., Roche Diagnostics, T2 Biosystems, Inc., OpGen, Inc., Schenker Biological Technology Co., Ltd., and HiMedia Laboratories Pvt. Ltd. are a some of the well-known companies in the blood culture test market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved